Speeches, Articles and Testimony

Refine your results

Filtros

Topic

Type

Fecha

Start Date

End Date

Displaying 361 - 380 of 3926

Show:

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of X-Mode Social, Inc. and Outlogic, LLC

Date

9 de Ene de 2024

Lina M. Khan, Former Chair and Commissioner

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya In the Matter of X-Mode Social, Inc. and Outlogic, LLC (180.08 KB)

Related Releases

FTC Order Prohibits Data Broker X-Mode Social and Outlogic from Selling Sensitive Location Data

SBLA Beauty

Resolution of NAD referral

Date

4 de Ene de 2024

Courtney A. Estep, Chief of Staff for Advertising Practices

Resolution Letter (181.79 KB)

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding the FY2022 HSR Annual Report to Congress

Date

21 de Dic de 2023

Matter Number

P110014

Lina M. Khan, Former Chair and Commissioner

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding the FY2022 HSR Annual Report to Congress (148 KB)

Related Releases

FTC, DOJ Issue Fiscal Year 2022 Hart-Scott-Rodino Notification Report

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter In the Matter of Sanofi/Maze Therapeutics

Date

20 de Dic de 2023

Matter Number

D09422

Lina M. Khan, Former Chair and Commissioner;

Rebecca Kelly Slaughter, Former Commissioner

Text of Statement (126.92 KB)

Statement of Commissioner Alvaro M. Bedoya On the Issuance of the Notice of Proposed Rulemaking to Update the Children's Online Privacy Protection Rule (COPPA Rule)

Date

20 de Dic de 2023

Alvaro Bedoya, Former Commissioner

Statement of Commissioner Alvaro M. Bedoya On the Issuance of the Notice of Proposed Rulemaking to Update the Children's Online Privacy Protection Rule (COPPA Rule) (315.75 KB)

Related Releases

FTC Proposes Strengthening Children’s Privacy Rule to Further Limit Companies’ Ability to Monetize Children’s Data

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter In the Matter of Sanofi/Maze Therapeutics

Date

20 de Dic de 2023

Matter Number

D09422

Lina M. Khan, Former Chair and Commissioner;

Rebecca Kelly Slaughter, Former Commissioner

Text of Statement (126.92 KB)

Statement of Commissioner Alvaro M. Bedoya On FTC v. Rite Aid Corporation

Date

19 de Dic de 2023

Matter Number

2023190

Alvaro Bedoya, Former Commissioner

Statement of Commissioner Alvaro M. Bedoya On FTC v. Rite Aid Corporation (213.85 KB)

Related Releases

Rite Aid Banned from Using AI Facial Recognition After FTC Says Retailer Deployed Technology without Reasonable Safeguards

Letter From Chair Khan to Rep. Tiffany Regarding Merger Challenges

Date

3 de Nov de 2023

Lina M. Khan, Former Chair and Commissioner

Letter From Chair Khan to Rep. Tiffany Regarding Merger Challenges (253.93 KB)

Appendix A - FTC Merger Enforcement (134.79 KB)

Remarks of Chair Lina M. Khan at Stanford Institute for Economic Policy Research

Date

2 de Nov de 2023

Lina M. Khan, Former Chair and Commissioner

Remarks of Chair Lina M. Khan at Stanford Institute for Economic Policy Research (230.04 KB)

Remarks of Chair Lina M. Khan White House Convening on Right to Repair

Date

25 de Oct de 2023

Lina M. Khan, Former Chair and Commissioner

Remarks of Chair Lina M. Khan White House Convening on Right to Repair (142.76 KB)

Remarks of Chair Lina M. Khan at the International Competition Network Conference

Date

18 de Oct de 2023

Lina M. Khan, Former Chair and Commissioner

Remarks of Chair Lina M. Khan at the International Competition Network Conference (220.95 KB)

Remarks of Chair Lina M. Khan at the American College of Emergency Physicians Annual Conference

Date

11 de Oct de 2023

Lina M. Khan, Former Chair and Commissioner

Remarks of Chair Lina M. Khan at the American College of Emergency Physicians Annual Conference (163.1 KB)

Remarks of Chair Lina M. Khan Regarding the White House Announcement of New Actions to Protect Consumers from Hidden Junk Fees

Date

10 de Oct de 2023

Lina M. Khan, Former Chair and Commissioner

Remarks of Chair Lina M. Khan Regarding the White House Announcement of New Actions to Protect Consumers from Hidden Junk Fees (157.72 KB)

Remarks of Chair Khan As Prepared for Delivery Creative Economy and Generative AI Roundtable

Date

4 de Oct de 2023

Lina M. Khan, Former Chair and Commissioner

Remarks of Chair Khan As Prepared for Delivery Creative Economy and Generative AI Roundtable (188.56 KB)

Remarks of Chair Lina M. Khan as Prepared for Delivery at the Fordham 50th Annual Conference on International Antitrust Law & Policy

Date

22 de Sep de 2023

Lina M. Khan, Former Chair and Commissioner

Remarks of Chair Lina M. Khan as Prepared for Delivery - Fordham 50th Annual Conference on International Antitrust Law & Policy (235.91 KB)

Remarks of BCP Director Samuel Levine at 2023 Consumer Data Industry Association Law & Industry Conference

Date

21 de Sep de 2023

Samuel Levine, Former Director, Bureau of Consumer Protection

Remarks of BCP Director Samuel Levine at 2023 Consumer Data Industry Association Law & Industry Conference (262.74 KB)

Remarks of BCP Director Samuel Levine at The National Advertising Division Annual Conference 2023

Date

19 de Sep de 2023

Samuel Levine, Former Director, Bureau of Consumer Protection

Remarks of BCP Director Samuel Levine at The National Advertising Division Annual Conference 2023 (337.35 KB)

Federal Trade Commission Statement Concerning Brand Drug Manufacturers' Improper Listing of Patents in the Orange Book

Concerning Brand Drug Manufacturers' Improper Listing of Patents in the Orange Book

Date

14 de Sep de 2023

Matter Number

P233900

Federal Trade Commission (FTC)

Text of the Policy Statement (633.47 KB)

Related Releases

FTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’

Statement of Chair Lina M. Khan at the September Open Commission Meeting on Brand Drug Manufacturers’ Improper Listing of Patents in the Orange Book

Date

14 de Sep de 2023

Lina M. Khan, Former Chair and Commissioner

Statement of Chair Lina M. Khan at the September Open Commission Meeting on Brand Drug Manufacturers’ Improper Listing of Patents in the Orange Book (186.42 KB)

Related Releases

FTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc

Date

1 de Sep de 2023

Lina M. Khan, Former Chair and Commissioner;

Alvaro Bedoya, Former Commissioner;

Rebecca Kelly Slaughter, Former Commissioner

Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc (231.33 KB)

Related Releases

Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition

Displaying 361 - 380 of 3926

Join us at the FTC!

View our open positions

Speeches, Articles and Testimony by

Refine your results

Refine your results